Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
Tommaso Schioppo, Lorenza Maria Argolini, Savino Sciascia, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 5, pp. 1928-1935
Open Access | Times Cited: 19

Showing 19 citing articles:

The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
Yan Xie, Yang Liu, Yi Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Systemic lupus erythematosus: latest insight into etiopathogenesis
Akhil Akhil, Rohit Bansal, Kumari Anupam, et al.
Rheumatology International (2023) Vol. 43, Iss. 8, pp. 1381-1393
Open Access | Times Cited: 32
Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management
Pankti Mehta, Armen Yuri Gasparyan, Olena Zimba, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 9, pp. 2893-2910
Open Access | Times Cited: 33
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases
Zahra Hamidi, Shaghaiegh Jabraeili-Siahroud, Yalda Taati-Alamdari, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 20
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study
Xiaofeng Jiang, Jeffrey A. Sparks, Zachary S. Wallace, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002839-e002839
Open Access | Times Cited: 10
De novo lupus nephritis after SARS-CoV-2 infection
Chi Chiu Mok, Chiu Sum Chu, Sau Mei Tse
Lupus (2023) Vol. 32, Iss. 7, pp. 893-899
Open Access | Times Cited: 8
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan Volkers, Luuk Wieske, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Systemic lupus erythematosus flare during SARS‐CoV‐2 infection: Report of 3 cases presented during the fourth wave of the pandemic in Colombia
Julián Naranjo-Millán, Vanessa Bedoya‐Joaqui, Carlos A. Cañas
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 9, pp. 1807-1810
Closed Access | Times Cited: 5
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases
Giuseppe A. Ramirez, Chiara Asperti, Valentina Cucca, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1147-1147
Open Access | Times Cited: 10
Distinct Clinical Manifestations of COVID-19 in Multiple Sclerosis Patients: Unraveling the Clinical Nexus
Amir Aboofazeli, Mozhgan Mondeali, Roxana Tajdini, et al.
Archives of Neuroscience (2024) Vol. 11, Iss. 2
Open Access | Times Cited: 1
Multi-omics analysis uncovered systemic lupus erythematosus and COVID-19 crosstalk
Zekai Nian, Yicheng Mao, Zexia Xu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Cyclosporine may reduce the risk of symptomatic COVID-19 in patients with systemic lupus erythematosus: a retrospective cohort study
Hejun Li, Rose Lin, Yanqing Wang, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 1
Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in Japan
Kenji Oku, Yasutaka Kimoto, Takahiko Horiuchi, et al.
Modern Rheumatology (2022) Vol. 33, Iss. 4, pp. 768-776
Closed Access | Times Cited: 5
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan Volkers, Luuk Wieske, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Vaccinations avant et après greffe de cellules hématopoïétiques autologues chez les patients atteints de maladies auto-immunes : propositions du groupe Maladies Auto-immunes et Thérapie Cellulaire de la SFGM-TC
A. Maria, Arnaud Campidelli, Cristina Castilla‐Llorente, et al.
Bulletin du Cancer (2023) Vol. 110, Iss. 2, pp. S97-S107
Open Access | Times Cited: 1
Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case–control study
Chi Chiu Mok, Chris Ching Lam Cheung, Kar Li Chan, et al.
Lara D. Veeken (2023)
Closed Access | Times Cited: 1
Microorganisms in Pathogenesis and Management of Systemic Lupus Erythematosus (SLE)
Ping Yi, Ming Zhao, Qianjin Lu
(2022), pp. 507-551
Closed Access | Times Cited: 1
Rheumatoid arthritis, multiple sclerosis and lupus: key points from the COVID-19 era
J. M. Silva, Fátima Silva, Sandra Clara Soares
International Journal of Research in Medical Sciences (2023) Vol. 11, Iss. 6, pp. 2214-2236
Open Access
Systemic lupus erythematosus after SARS‐CoV‐2 infection: A causal or temporal relationship?
Abraham Edgar Gracia‐Ramos, Miguel Ángel Saavedra
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 12, pp. 2373-2376
Open Access
Page 1

Scroll to top